Advice
Following an abbreviated submission
Formoterol 12 micrograms metered inhaler (Atimos Modulite) is accepted for use in NHS Scotland for the long-term symptomatic treatment of persistent, moderate to severe asthma in patients requiring regular bronchodilator therapy in combination with long-term anti-inflammatory therapy (inhaled and/or oral glucocorticoids).
It should be used in patients for whom formoterol is an appropriate choice of long-acting beta-agonist and for whom a metered dose inhaler is an appropriate delivery device.
Download detailed advice28KB (PDF)
Medicine details
- Medicine name:
- formoterol 12 micrograms metered dose inhaler (Atimos Modulite®)
- SMC ID:
- 239/06
- Indication:
- Asthma
- Pharmaceutical company
- Trinity Chiesi Pharmaceuticals
- BNF chapter
- Respiratory system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 13 February 2006